219 related articles for article (PubMed ID: 8521771)
1. Nifedipine gastrointestinal therapeutic system (GITS). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and angina pectoris.
Brogden RN; McTavish D
Drugs; 1995 Sep; 50(3):495-512. PubMed ID: 8521771
[TBL] [Abstract][Full Text] [Related]
2. P&T Committee review of nifedipine GITS: new modality for angina and hypertension.
Weintraub M; Horn J; Krakoff L; Vetrovec G
Hosp Formul; 1990 Mar; 25 Suppl A():10-4. PubMed ID: 10103975
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of nifedipine gastrointestinal therapeutic system versus diltiazem when added to beta blockers in stable angina pectoris.
Siu SC; Jacoby RM; Phillips RT; Nesto RW
Am J Cardiol; 1993 Apr; 71(11):887-92. PubMed ID: 8096670
[TBL] [Abstract][Full Text] [Related]
4. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.
Grundy JS; Foster RT
Clin Pharmacokinet; 1996 Jan; 30(1):28-51. PubMed ID: 8846626
[TBL] [Abstract][Full Text] [Related]
5. Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris.
Croom KF; Wellington K
Drugs; 2006; 66(4):497-528. PubMed ID: 16597165
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
Fagan TC; Haggert BE; Liss C
Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
[TBL] [Abstract][Full Text] [Related]
7. Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.
Murdoch D; Brogden RN
Drugs; 1991 May; 41(5):737-79. PubMed ID: 1712708
[TBL] [Abstract][Full Text] [Related]
8. Once daily nifedipine: the formulation dictates the pharmacokinetic characteristics and the therapeutic responses.
Toal CB; Meredith PA; Elliott HL
Int J Clin Pharmacol Ther; 2012 Mar; 50(3):202-17. PubMed ID: 22373833
[TBL] [Abstract][Full Text] [Related]
9. Innovative drug delivery systems in cardiovascular medicine: nifedipine-GITS and clonidine-TTS.
Frishman WH; Sherman D; Feinfeld DA
Cardiol Clin; 1987 Nov; 5(4):703-16. PubMed ID: 3331321
[TBL] [Abstract][Full Text] [Related]
10. Early experience with dobutamine stress testing and cardiac cine-tomographic imaging in the elderly: antianginal effects of nifedipine-GITS.
Schwartz JB; Caputo G; Abbott J
J Am Geriatr Soc; 1993 Sep; 41(9):967-74. PubMed ID: 8409183
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina.
Toal CB; Motro M; Baird MG; Klinke P; Sclarowski S; Zilberman A; Marmor A; Kostuk WJ; Lotan C; Weiss A; Erne P; Palant A; Stolero D; Bélanger L; Turpie A
Can J Cardiol; 1999 Oct; 15(10):1103-9. PubMed ID: 10523477
[TBL] [Abstract][Full Text] [Related]
12. Monotherapy with nifedipine GITS compared with atenolol in stable angina pectoris. The Working Group on Cardiovascular Research (WCN).
de Vries RJ; Dunselman PH
Br J Clin Pract Suppl; 1997 Apr; 88():6-9. PubMed ID: 9519501
[TBL] [Abstract][Full Text] [Related]
13. Once-daily therapy for angina pectoris with nifedipine gastrointestinal therapeutic system. Dosing and clinical efficacy.
Vetrovec GW
Am J Med; 1989 Jan; 86(1A):28-32. PubMed ID: 2644830
[TBL] [Abstract][Full Text] [Related]
14. Nifedipine gastrointestinal therapeutic system in stable angina pectoris. Results of a multicenter open-label crossover comparison with standard nifedipine.
Vetrovec GW; Parker VE; Cole S; Procacci PM; Tabatznik B; Terry R
Am J Med; 1987 Dec; 83(6B):24-9. PubMed ID: 3140660
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension. Nifedipine Study Group.
Glasser SP; Jain A; Allenby KS; Shannon T; Pride K; Pettis PP; Schwartz LA; MacCarthy EP
Clin Ther; 1995; 17(1):12-29. PubMed ID: 7758054
[TBL] [Abstract][Full Text] [Related]
16. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
Friedel HA; Sorkin EM
Drugs; 1988 Dec; 36(6):682-731. PubMed ID: 3065058
[TBL] [Abstract][Full Text] [Related]
17. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
Brogden RN; Markham A
Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062
[TBL] [Abstract][Full Text] [Related]
18. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
[TBL] [Abstract][Full Text] [Related]
19. Medical therapy, symptoms, and the distress the cause: relation to quality of life in patients with angina pectoris and/or hypertension.
Hollenberg NK; Williams GH; Anderson R
Arch Intern Med; 2000 May; 160(10):1477-83. PubMed ID: 10826461
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
Verdecchia P
Minerva Cardioangiol; 1993 Sep; 41(9):349-63. PubMed ID: 7903118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
